ArticleCancers2025
Feasibility and Acceptability of the Cancer-Specific PRONTO Protocol for Nutritional Risk Screening in Outpatient Oncology Cancer Care: A Pilot Study.
Darío Sánchez-Cabrero, Jaime Rubio, Jorge Durá Esteve, Laura Guzmán-Gómez, Germán Guzmán-Rolo, Cristina Grande, Andrea Martín Aguilar, Pablo Pérez-Wert, Ana Pertejo, Suela Sulo and 4 more
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Darío Sánchez-CabreroBiomarkers and Experimental Therapeutics in Cancer, Instituto de Investigación Sanitaria del Hospital Universitario La Paz, 28046 Madrid, Spain.
Jaime RubioCancer Unit for Research on Novel Therapeutic Targets, Oncohealth Institute, IIS-Fundación Jiménez Díaz, UAM, 28040 Madrid, Spain.ORCID 0000-0002-3794-9119 Jorge Durá EsteveMedical Oncology Department, La Paz University Hospital, 28046 Madrid, Spain.
Laura Guzmán-GómezRadiation Oncology Department, University Hospital "Fundación Jiménez Díaz", 28040 Madrid, Spain.ORCID 0009-0009-3223-6089 Cristina GrandeGlobal Medical Affairs and Research, Abbott Nutrition, 28050 Madrid, Spain.
Andrea Martín AguilarGlobal Medical Affairs and Research, Abbott Nutrition, 28050 Madrid, Spain.
Ana PertejoMedical Oncology Department, La Paz University Hospital, 28046 Madrid, Spain.
Suela SuloGlobal Medical Affairs and Research, Abbott Nutrition, Chicago, IL 60064, USA.
Samara Palma MillaClinical Nutrition and Dietetics Unit, Endocrinology and Nutrition Department, Hospital Universitario La Paz, Biomedical Research Institute (IdiPAZ), 28049 Madrid, Spain.ORCID 0000-0002-0187-1495 Carolina DassenService of Endocrinology and Nutrition, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
Maurizio MuscaritoliDepartment of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-1955-6116 Funding
Abbott Nutrition (United States) NA
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cancernutritional riskPRONTOsarcopeniascreeningusability
Identifiers
PMID41301062
PMCPMC12651754
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390